Massive medicare study tracks safety of tiny leadless pacemakers
NCT ID NCT03039712
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study follows about 37,000 Medicare patients who received a Micra leadless pacemaker to treat slow heart rate (bradycardia). Researchers use insurance claims to check for complications within 30 days and survival rates over two years. The goal is to gather real-world safety data required by Medicare, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRADYCARDIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University
Atlanta, Georgia, 30308, United States
Conditions
Explore the condition pages connected to this study.